XML 99 R58.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Investments                    
Fixed maturities available-for-sale, at fair value (amortized cost: $698.6 million and $6.4 million as of September 30, 2021 and December 31, 2020) $ 697.6     $ 6.6       $ 5.9    
Short-term investments (cost: $107.5 million) 107.5     0.0       54.7    
Total investments 805.1     6.6       60.6    
Cash, cash equivalents and restricted cash 319.6     571.4 $ 575.7     270.3 $ 102.4 $ 16.9
Premium receivable, net of allowance for doubtful accounts of $0.5 million and $0.2 million as of December 31, 2020 and 2019 129.2     86.1       54.1    
Reinsurance recoverable 70.8     49.0       20.3    
Prepaid reinsurance premium 150.2     91.3       1.0    
Deferred acquisition costs 6.0     3.5       1.8 0.6  
Property and equipment, net 10.8     5.7       3.1    
Intangible assets       0.6       0.6    
Other assets 29.4     14.5       2.5    
Total assets 1,521.7     828.7       414.3    
Liabilities, Convertible Preferred Stock and Stockholders' Equity (Deficit)                    
Unpaid losses and loss adjustment expenses 74.0     46.3 39.7     28.2 13.1  
Unearned premium 203.2     123.8       68.0    
Trade payables 3.0     1.4       0.7    
Funds held for reinsurance treaties 97.1     62.1       0.0    
Other liabilities and accrued expenses 35.5     18.7       19.7    
Total liabilities 473.7     287.7       116.6    
Commitments and contingencies (Note 20)              
Convertible preferred stock (Series Seed, A, B, C, and D), $0.00001 par value; no shares issued, authorized and outstanding as of December 31, 2020; 31,557,107 shares authorized, issued and outstanding as of December 31, 2019; aggregate liquidation preference of $0.0 million and $480.8 million on as of December 31, 2020 and 2019, respectively 0.0 $ 0.0 $ 0.0 0.0 0.0 $ 480.2 $ 480.2 480.2 180.8 60.4
Stockholders' equity (deficit):                    
Common stock, $0.00001 par value, 200,000,000 shares and 52,000,000 shares authorized as of December 31, 2020 and 2019 , respectively; 56,774,294 shares and 11,784,765 shares issued and 56,774,294 shares and 11,271,228 shares outstanding as of December 31, 2020 and 2019, respectively 0.0     0.0       0.0    
Additional paid-in capital 1,539.5     859.8       15.7    
Accumulated deficit (491.6)     (320.6)       (198.3)    
Accumulated other comprehensive income 0.1     1.8       0.1    
Total stockholders' equity 1,048.0 $ 1,101.6 $ 1,143.7 541.0 $ 569.0 $ (221.6) $ (204.6) (182.5) $ (79.1) $ (28.4)
Total liabilities and stockholders' equity $ 1,521.7     $ 828.7       $ 414.3